| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $521.3M | +54.7% |
| R&D Expense | $186.2M | +32.4% |
| SG&A Expense | $257.0M | +27.1% |
| Operating Income | -$22.1M | +74.7% |
| Pre-tax Income | -$21.4M | +75.3% |
| Income Tax | $1.9M | +88.0% |
| Net Income | -$23.4M | +73.4% |
| EPS (Basic) | -$0.47 | +74.6% |
| EPS (Diluted) | -$0.47 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $296.7M | +33.3% |
| Short-term Investments | $86.6M | +49.9% |
| Accounts Receivable | $123.3M | +57.5% |
| Inventory | $24.9M | +11.1% |
| Current Assets | $549.7M | +39.9% |
| Total Assets | $842.8M | +25.7% |
| Current Liabilities | $205.8M | +62.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $55.8M | +440.7% |
| Capital Expenditures | $954K | -3.9% |
| Investing Cash Flow | -$24.0M | +73.4% |
| Financing Cash Flow | $40.1M | +126.8% |
| Free Cash Flow | $54.9M | +488.0% |
| +74.6% |
| Total Liabilities |
| $528.1M |
| +18.6% |
| Stockholders' Equity | $314.7M | +39.5% |